Psychosocial aspects of systemic sclerosis

Current Opinion in Rheumatology

Volumn 25, Issue 6, 2013, Pages 707-713

  Malcarne, Vanessa L ^a,b   Fox, Rina S ^b   Mills, Sarah D ^b   Gholizadeh, Shadi ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Psychosocial; Scleroderma; Systemic sclerosis

Indexed keywords

ANXIETY DISORDER; BODY IMAGE; BREATHING; DEPRESSION; FATIGUE; HEALTH CARE NEED; HUMAN; MOOD DISORDER; OUTCOME ASSESSMENT; PAIN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SOCIAL PSYCHOLOGY; STRUCTURED INTERVIEW; SYSTEMIC SCLEROSIS; WORK DISABILITY; WORKPLACE;

BODY DYSMORPHIC DISORDERS; DEPRESSION; FATIGUE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MENTAL DISORDERS; PAIN; PRURITUS; SCLERODERMA, SYSTEMIC; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SLEEP DISORDERS; WORK CAPACITY EVALUATION;

EID: 84885207819     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/01.bor.0000434666.47397.c2     Document Type: Review

References (65)

1. Thombs BD, van Lankveld W, Bassel M, et al. Psychological health and well being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res 2010; 62:1181-1189
2. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: A systematic review of the evidence. Arthritis Rheum 2007; 57:1089-1097
3. .Mura G, Krishna MB, Pisano A, et al. Psychiatric symptoms and quality of life in systemic sclerosis. Clin Pract Epidemiol Ment Health 2012; 8:30-35
4. Wafki F, Amine B, Ibn Yacoub Y, et al. Depression among the Moroccan systemic sclerosis. Clin Rheumatol 2012; 31:73-77
5. Kwakkenbos L, van Lankveld WG, Vonk MC, et al. Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosomatic Res 2012; 72:199-204
6. .Müller H, Rehberger P, Günther C, Schmitt J. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. British J Derm 2012; 166:343-353
7. .Jewett LR, Razykov I, Hudson M, et al. Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatol (Oxford) 2013; 52:669-675
8. .Baubet T, Ranque B, Taieb O, et al. Mood and anxiety disorders in systemic sclerosis patients. Presse Med 2011; 40:e111-e119
9. Bodukam V, Hays RD, Maranian P, et al. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatol (Oxford) 2011; 50:330-334
10. Nguyen C, Bé rezné A, Baubet T, et al. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS ONE 2011; 6:e17551
11. Kwakkenbos L, Arthurs E, van den Hoogen FH, et al. Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) Scale in systemic sclerosis: A comparison of Canadian and Dutch patients. PLoS One 2013; 8:e53923]. doi:10.1371/journal.pone. 0053923
12. Arthurs E, Steele RJ, Hudson M, et al. Are scores on English and French versions of thePHQ-9comparable?Anassessment of differential itemfunctioning. PLoS ONE 2012; 7:e52028. doi:10.1371/journal.pone.0052028
13. .Leavens A, Patten SB, Hudson M, et al. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res 2012; 64:1195-1201
14. .Razykov I, HudsonM, Baron M, et al. The utility of the PHQ-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res 2013; 65:753-758
15. Newton EG, Thombs BD, Groleau D. The experience of emotional distress among women with scleroderma. Qualitative Health Res 2012; 22:1195-1206
16. .Bassel M, Hudson M, Taillefer SS, et al. Frequency and impact of symptoms experienced by patients with systemic sclerosis: Results from a Canadian National Survey. Rheumatology (Oxford) 2011; 50:762-767
17. Ibn Yacoub Y, Amine B, Bensabbah R, Hajjaj-Hassouni N. Assessment of fatigue and its relationship with disease-related parameters in patients with systemic sclerosis. Clin Rheumatol 2012; 31:655-660
18. Strickland G, Pauling J, Cavill C, McHugh N. Predictors of health-related quality of life and fatigue in systemic sclerosis: Evaluation of the EuroQol-5D and FACIT-F assessment tools. Clin Rheumatol 2012; 31:1215-1222
19. .Harel D, Thombs BD, Hudson M, et al. Measuring fatigue in SSc: A comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale. Rheumatology (Oxford) 2012; 51: 2177-2185
20. Sandqvist G, Archenholtz B, Scheja A, Hesselstrand R. The Swedish version of the Multidimensional Assessment of Fatigue (MAF) in systemic sclerosis: Reproducibility and correlations to other fatigue instruments. Scand J Rheumatol 2011; 40:493-494
21. .Assassi S, Leyva AL, Mayes MD, et al. Predictors of fatigue severity in early systemic sclerosis: A prospective longitudinal study of the GENISOS cohort. PLoS ONE 2011; 6:e26061
22. .Frech T, Hays RD, Maranian P, et al. Prevalence and correlates of sleep disturbance in systemic sclerosis: Results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 2011; 50:1280-1287
23. Milette K, Razykov I, Pope J, et al. Clinical correlates of sleep problems in systemic sclerosis: The prominent role of pain. Rheumatology (Oxford) 2011; 50:921-925
24. .El-Baalbaki G, Lober J, Hudson M, et al. Measuring pain in systemic sclerosis: Comparison of the short-form McGill Pain Questionnaire versus a single-item measure of pain. J Rheumatol 2011; 38:2581-2587
25. Chularojanamontri L, Sethabutra P, Kulthanan K, Manapajon A. Dermatology life quality index in Thai patients with systemic sclerosis: A cross-sectional study. Indian J Dermatol Venereol Leprol 2011; 77:683-687
26. Jewett LR, Hudson M, Haythornthwaite JA, et al. Development and validation of the brief-Satisfaction with Appearance scale for systemic sclerosis. Arthritis Care Res 2010; 62:1779-1786
27. .Jewett LR, Hudson M, Malcarne VL, et al. Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis. PLoS One 2012; 7:e33281. doi:10.1371/journal.pone.0033281
28. Lawrence JW, Heinberg LJ, Roca R, et al. Development and validation of the satisfaction with appearance scale: Assessing body image among burn-injury patients. Psychol Assessment 1998; 10:64-70
29. .Amin K, Clarke A, Sivakumar B, et al. The psychological impact of facial changes in scleroderma. Psychol Health Med 2011; 16:304-312
30. Carr T, Moss T, Harris D. The DAS24: A short form of the Derriford Appearance Scale DAS59 to measure individual responses to living with problems of appearance. Br J Health Psychol 2005; 10:285-298
31. .Levis B, Burri A, Hudson M, et al. Sexual activity and impairment in women with systemic sclerosis compared to women from a general population sample. PLoS ONE 2012; 7:e52129. doi:10.1371/journal.pone.0052129
32. .Levis B, Hudson M, Knafo R, et al. Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthritis CareRes 2012; 64:340-350
33. .Knafo R, Haythornthwaite JA, Heinberg L, et al. The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis. Rheumatology (Oxford) 2011; 50:1125-1130
34. Walker UA, Tyndall A, Ruszat R. Erectile dysfunction in systemic sclerosis. Ann Rheum Dis 2009; 68:1083-1085
35. .Foocharoen C, Tyndall A, Hachulla E, et al. Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: A study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther 2012; 14:R37
36. .Schouffoer AA, Schoones JW, Terwee CB, Vlieland TPV. Work status and its determinants among patients with systemic sclerosis: A systematic review. Rheumatology (Oxford) 2012; 51:1304-1314
37. .Sharif R, Mayes MD, Nicassio PM, et al. Determinants of work disability in patients with systemic sclerosis: A longitudinal study of the GENISOS Cohort. Seminars Arthtiris Rheum 2011; 41:38-47
38. .Singh MK, Clements PJ, Furst DE, et al. Work productivity in scleroderma: Analysis from the University of California, Los Angeles scleroderma quality of life study. Arthritis Care Res 2012; 64:176-183
39. Bé rezné A, Seror R, Morell-Dubois S, et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res 2011; 63:277-285
40. .Decuman S, Smith V, Verhaeghe S, et al. Work participation and work transition in patients with systemic sclerosis: A cross-sectional study. Rheumatology (Oxford) 2012; 51:297-304
41. Sandqvist G, Hesselstrand R, Scheja A, Hakansson C. Managing work life with systemic sclerosis. Rheumatology (Oxford) 2012; 51:319-323
42. .Poole JL, Willer K, Mendelson C, et al. Perceived parenting ability and systemic sclerosis. Musculoskeletal care 2011; 9:32-40
43. .Schouffoer AA, Zirkzee EJ, Henquet SM, et al. Needs and preferences regarding healthcare delivery as perceived by patients with systemic sclerosis. Clin Rheumatol 2011; 30:815-824
44. .Stamm TA, Mattsson M, Mihai C, et al. Concepts of functioning and health important to people with systemic sclerosis: A qualitative study in four European countries. Ann Rheum Dis 2011; 70:1074-1079
45. Cinar FI, Unver V, Yilmaz S, et al. Living with scleroderma: Patients' perspectives, a phenomenological study. Rheumatol Int 2012; 32:3573-3579
46. Godard D The needs of patients with systemic sclerosis-what are the difficulties encountered? Autoimmun Rev 2011; 10:291-294
47. .Rehberger P, Müller H, Günther C, Schmitt J. Treatment satisfaction and health status in patients with systemic sclerosis. J Dtsch Dermatol Ges 2012; 10:905-911
48. .Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res 2011; 63:909-917
49. van der Vaart R, Repping-Wuts H, Drossaert CH, et al. Needs for online information and support of patients with systemic sclerosis. Arthritis Care Res 2013; 65:594-600
50. Baker NA, Aufman EL, Poole JL. Computer use problems and accommodation strategies at work and home for people with systemic sclerosis: A needs assessment. Am J Occup Ther 2012; 66:368-375
51. .Khanna D, Maranian P, Rothrock N, et al. Feasibility and construct validity of PROMIS and Legacy Instruments in an academic scleroderma clinic-Analysis from the UCLA Scleroderma Quality of Life Study. Value Health 2012; 15:128-134
52. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: Plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 2007; 45:S22-S31
53. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010; 63:1179-1194
54. Yount SE, Choi SW, Victorson D, et al. Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD). Value Health 2011; 14:307-315
55. Hinchcliff M, Beaumont JL, Thavarajah K, et al. Validity of two new patient reported outcome measures in systemic sclerosis: The PROMIS-29 Profile and the FACIT-Dyspnea. Arthritis Care Res 2011; 63:1620-1628
56. Kirwan JR, Tugwell PS. Overview of the patient perspective at OMERACT 10-Conceptualizing methods for developing patient-reported outcomes. J Rheumatol 2011; 38:1699-1701
57. .Merz EL, Malcarne VL, Roesch SC, et al. Measuring illness behavior in patients with systemic sclerosis. Arthritis Care Res 2013; 65:585-593
58. Khanna D, Hays RD, Maranian P, et al. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum 2009; 61:1257-1263
59. .Khanna D, Furst DR, Maranian P, et al. Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. J Rheumatol 2011; 38:1920-1924
60. Kwakkenbos L, van den Hoogen FH, Custers J, et al. Validity of the Fear of Progression Questionnaire Short Form in patients with systemic sclerosis. Arthritis Care Res 2012; 64:930-934
61. Xinyi NG, Thumboo J, Low AHL. Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 2012; 15:268-276
62. Bae S, Allanore Y, Coustet B, et al. Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Clin Exp Rheumatol 2011; 29:S15-S21
63. .Kwakkenbos L, Bluyssen SJ, Vonk MC, et al. Addressing patient healthcare demands in systemic sclerosis: Prepost assessment of a psycho-educational group programme. Clin Exp Rheumatol 2011; 29:S60-S65
64. .Thombs BD, Jewett LR, Assassi S, et al. New directions for patient-centred care in scleroderma: The Scleroderma Patient-centred Intervention Network (SPIN). Clin Exp Rheumatol 2012; 30 (Suppl 71):S23-S29
65. .Matsuura E, Ohta A, Suematsu R, et al. Functional disturbance of the stressadaptation system in patients with scleroderma. Mod Rheumatol 2011; 21:397-405